Page last updated: 2024-08-16

probucol and hr 780

probucol has been researched along with hr 780 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Makita, S; Oshima, K; Wajima, T	1

Other Studies

1 other study(ies) available for probucol and hr 780

Article	Year
Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Clinical and experimental pharmacology & physiology, 2003, Volume: 30, Issue:12 Topics: Animals; Aorta, Thoracic; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fetal Blood; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pravastatin; Probucol; Pyridines; Rabbits; Simvastatin; Swine; Xanthine; Xanthine Oxidase	2003

Article

Year

Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Clinical and experimental pharmacology & physiology, 2003, Volume: 30, Issue:12

Topics: Animals; Aorta, Thoracic; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fetal Blood; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pravastatin; Probucol; Pyridines; Rabbits; Simvastatin; Swine; Xanthine; Xanthine Oxidase

2003